Actelion Ltd:企業の戦略・SWOT・財務分析

◆英語タイトル:Actelion Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3763
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Actelion Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Actelion Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Actelion Ltd. (Actelion or ‘the company’) is a biopharmaceutical company focused on the discovery, development and commercialization of low molecular weight drugs to address high unmet medical needs. The company classifies its business into single segment, which primarily focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. It offers variety of drugs for the treatment of cardiovascular disorders, central nervous system disorders, infectious diseases, cancer, and immunological disorders. The company has its operations in North and South America, Europe and Asia Pacific. The company is headquartered in Allschwil, Switzerland.

Scope

- Detailed information on Actelion Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Actelion Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Actelion Ltd including a breakdown and examination of key business segments
- Intelligence on Actelion Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Actelion Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Actelion Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Actelion Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Actelion Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Actelion Ltd: Company Overview
Actelion Ltd: Overview and Key Facts
Actelion Ltd: Overview
Actelion Ltd: Key Facts
Actelion Ltd: Key Employees
Actelion Ltd: Key Employee Biographies
Actelion Ltd: Major Products and Services
Actelion Ltd: Company History
Actelion Ltd: Locations and Subsidiaries
Actelion Ltd: Key Competitors
Actelion Ltd: Company Analysis
Actelion Ltd: Business Description
Actelion Ltd: SWOT Analysis
Actelion Ltd: SWOT Overview
Actelion Ltd: Strengths
Actelion Ltd: Weaknesses
Actelion Ltd: Opportunities
Actelion Ltd: Threats
Actelion Ltd: Corporate Financial Deals Activity
Actelion Ltd: Financial Deals Overview
Actelion Ltd: Targets and Partners
Actelion Ltd: Top Deals 2015 – 2019YTD*
Actelion Ltd: Advisors
Actelion Ltd: Top Legal Advisors
Actelion Ltd: Top Financial Advisors
Actelion Ltd: Partnership
Actelion Ltd: Divestments
Actelion Ltd: Private Equity and Ownership
Actelion Ltd: Recent Developments
Actelion Ltd: News and Events Summary
Actelion Ltd: Business Expansion
Actelion Ltd: Corporate Governance
Actelion Ltd: Financial Deals
Actelion Ltd: Financial Performance
Actelion Ltd: Regulatory and Legal Events
Actelion Ltd: Research & Development
Actelion Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Actelion Ltd: Key Facts
Table 2: Actelion Ltd: Key Employees
Table 3: Actelion Ltd: Company History
Table 4: Actelion Ltd: Locations and Subsidiaries
Table 5: Actelion Ltd: Key Competitors
Table 6: Actelion Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Actelion Ltd: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Actelion Ltd: Targets and Partners
Table 9: Actelion Ltd: Top Deals 2015 - 2019YTD*
Table 10: Actelion Ltd: Legal Advisor Ranking by Value (US$m)
Table 11: Actelion Ltd: Financial Advisor Ranking by Value (US$m)
Table 12: Actelion Ltd: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 13: Actelion Ltd: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 14: Actelion Ltd: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 15: Actelion Ltd: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 16: Actelion Ltd: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)
Table 17: Actelion Ltd: News and Events Summary
Table 18: Actelion Ltd: Business Expansion
Table 19: Actelion Ltd: Corporate Governance
Table 20: Actelion Ltd: Financial Deals
Table 21: Actelion Ltd: Financial Performance
Table 22: Actelion Ltd: Regulatory and Legal Events
Table 23: Actelion Ltd: Research & Development
Table 24: Actelion Ltd: Strategy and Operations

★海外企業調査レポート[Actelion Ltd:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acron (AKRN):企業の財務・戦略的SWOT分析
    Acron (AKRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Ezaki Glico Co Ltd:企業の戦略・SWOT・財務情報
    Ezaki Glico Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Ezaki Glico Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Barra Resources Limited:企業の戦略・SWOT・財務分析
    Barra Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Barra Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Arch Pharmalabs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Arch Pharmalabs Ltd (Arch Pharmalabs) is a healthcare products company that offers pharmaceutical ingredients. The company manufactures, develops and markets active APIs and intermediates to innovator and generic pharmaceutical players. It offers products such as docetaxel anhydrous and trih …
  • Iberdrola SA (IBE):企業の財務・戦略的SWOT分析
    Iberdrola SA (IBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • AtriCure Inc (ATRC):医療機器:M&Aディール及び事業提携情報
    Summary AtriCure, Inc. (AtriCure) is a provider of medical devices for the treatment of atrial fibrillation (Afib) and related conditions. The company carries out the development, manufacture and sale of cardiac surgical ablation devices. Its major products include Isolator Synergy ablation system, …
  • Cingulate Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Cingulate Therapeutics LLC (Cingulate) is a clinical stage biopharmaceutical company that develops new drug products for the treatment of attention deficit and hyperactivity disorder. The company’s pipeline products comprise CTX-1301 and CTX-1302 utilize precision timed release (PTR) drug de …
  • Polymedco Inc-医療機器分野:企業M&A・提携分析
    Summary Polymedco Inc (Polymedco) is a medical device company that manufactures and markets laboratory instruments, reagents and kits. The company provides FIT testing, ESR testing, chemistry testing instruments, oc-auto fit, oc-lights fit, oc-auto sensor, diana, oc-automicro 80, epi procolon, sedit …
  • Sberbank of Russia:企業の戦略・SWOT・財務情報
    Sberbank of Russia - Strategy, SWOT and Corporate Finance Report Summary Sberbank of Russia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • University of Glasgow-製薬・医療分野:企業M&A・提携分析
    Summary University of Glasgow (UOG) is an educational and research institute that offers undergraduate, post graduate, and online programs. The institute operates through its departments for law, medicine, veterinary medicine and dentistry. It offers courses across various disciplines that include a …
  • Avedro Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • United Breweries Limited:企業の戦略・SWOT・財務情報
    United Breweries Limited - Strategy, SWOT and Corporate Finance Report Summary United Breweries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Genzyme Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosi …
  • Infogroup Inc:企業の戦略・SWOT・財務情報
    Infogroup Inc - Strategy, SWOT and Corporate Finance Report Summary Infogroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Reed’s, Inc.:企業の戦略・SWOT・財務分析
    Reed's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Reed's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sekisui Diagnostics LLC:製品パイプライン分析
    Summary Sekisui Diagnostics LLC (Sekisui Diagnostics), a subsidiary of Sekisui Chemical Co Ltd is a medical device company that develops, manufactures and supplies clinical diagnostic and research products. The company’s products include coagulation, clinical chemistry, virotech products, OSOM rapid …
  • DiaSorin S.p.A (DIA)-医療機器分野:企業M&A・提携分析
    Summary DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techni …
  • Japan Logistics Fund, Inc. :企業の戦略・SWOT・財務情報
    Japan Logistics Fund, Inc. - Strategy, SWOT and Corporate Finance Report Summary Japan Logistics Fund, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Success Universe Group Limited
    Success Universe Group Limited - Strategy, SWOT and Corporate Finance Report Summary Success Universe Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • RIKEN-製薬・医療分野:企業M&A・提携分析
    Summary RIKEN is a research organization, which carries out research in basic and applied sciences. Its research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and a cluster for industry partnerships. Its centers, laboratories and researc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆